Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report.

Anna L Lindahl Maarit J AhavaMia HaukipääHanna-Riikka KreiviAnne LipponenElisa Kortela

Published in: Infectious diseases (London, England) (2023)

Nirmatrelvir-ritonavir could offer a more accessible alternative to remdesivir. Further research and guidelines for persisting SARS-CoV-2 infection in immunocompromised patients are urgently needed.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
antiretroviral therapy
prognostic factors
peritoneal dialysis
respiratory failure
clinical practice
patient reported
sars cov
coronavirus disease
extracorporeal membrane oxygenation